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study investigated the impact of an acidic extracellular pH (pHe) on p120-catenin (p120-ctn) serine
phosphorylation. pH 6.6 treatment increased intracellular calcium levels, activated protein kinase C
(PKC)a and PKCd, and decreased serine phosphorylation of p120-ctn. Further knockdown of PKCa
and d by small interference RNA (siRNA) prevented the pH 6.6-induced downregulation of p120-
ctn at AJ and the serine dephosphorylation of p120-ctn. Moreover, PP2 pretreatment and siRNA of
c-Src abrogated the pH 6.6-induced PKCd activation. Together, the c-Src-PKCd cascade and PKCa reg-
ulate the acidic pHe-induced AJ disruption.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction The adhesiveness of epithelial cell is maintained by the AJ, whichDue to lack of cellular ATP and oxygen and a high degree of gly-
colysis, solid tumors have an acidic extracellular pH (pHe), ranging
from pH 5.8 to 7.4 [1]. An acidic pHe has been associated with the
invasive behavior of some types of tumor cells [2]. Most studies
have focused on the upregulation of metalloproteases under these
circumstances. Several factors, including type IV gelatinase, metal-
loprotease-2, metalloprotease-9, cathepsins B and C, and angio-
genic factors, have been reported to contribute to this acidic
pHe-mediated cell invasion [3]. Since the integrity of the adherens
junction (AJ) is disrupted during epithelial–mesenchymal transi-
tion and cell migration, we have focused on the effects of an acidic
pHe on AJ proteins.chemical Societies. Published by E
in; IgG-HC, immunoglobulin
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.is formed by transmembrane E-cadherin and catenins [4,5]. p120-
Catenin (p120-ctn), a substrate of Src family kinases (SFKs), shares
similar armadillo repeats with b-catenin (b-ctn) and binds to the
juxtamembrane domain of cadherin [6]. The association of p120-
ctn and cadherin protects the intracellular domain of cadherin from
targeting by some kinases, and poor binding of p120-ctn to cad-
herin may result in degradation or endocytosis of cadherin [7,8].
Protein Kinase C (PKC) is involved in vascular permeability by
regulating phosphorylation of b-ctn and p120-ctn and the break-
down of vascular-endothelial cadherin [9,10]. Activation of PKC in-
duces either dephosphorylation or phosphorylation of p120-ctn at
different residues [11,12]. Recent study indicates that in MDCK
cells, p120-ctn phosphorylation at Ser879 induced by platelet-
derived growth factor is mediated by PKCa [13]. Whether other
PKC isoforms regulate the phosphorylation of p120-ctn remains
to be explored. This study examined (1) the role of PKCa and PKCd
in p120-ctn serine dephosphorylation induced by an acidic pHe,
and (2) the possible link between SFKs and PKCd in HepG2 cells.
2. Materials and methods
2.1. Cell culture
The human hepatocellular carcinoma cell line HepG2 (ATCC,
HB8065) were purchased from the American Type Culture Collec-
tion (Rockville, MD), and cultured as previously described [14].lsevier B.V. All rights reserved.
Fig. 1. pH 6.6 induces calcium inﬂux and phosphorylation of PKCa and PKCd. pH 6.6
increases intracellular calcium levels analyzed by ﬂow cytometry (A). The cells were
cultured at pH 6.6 for 0, 30, 60, 120, 180 or 240 min, and the cell homogenates were
analyzed for phosphoserine 657-PKCa and total PKCa (B) or phosphotyrosine 311-
PKCd and GAPDH (C). A typical blot is shown in the upper panel and the mean ± S.D.
for densitometric scans of three blots in the lower panel. ⁄P < 0.05, compared to the
0 min-group.
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ium at pH 6.6 at 37 C in a CO2 incubator with 5% CO2 and 95% air
for the indicated period. The controls were cells incubated in
growth medium at pH 7.4.
2.2. Inhibitors and antibodies
Gö6976, rottlerin, and PP2 were purchased from Biomol Re-
search Laboratory Inc (Plymouth Meeting, PA). For Western blot-
ting, the primary antibodies were rabbit polyclonal antibodies
against PKCa PKCd (Santa Cruz Biotechnology, Santa Cruz, CA),
phospho-Tyr311-PKCd (Epitomics Inc, Burlingame, CA), phos-
phor-Ser657-PKCa (Millipore corporation, Billerica, MA), GAPDH
(BioVision Research Products, Mountain View, CA), or mouse
monoclonal antibodies against b-actin (Sigma, Saint Louis) or
p120-ctn (BD Biosource, San Joe, CA). The secondary antibodies
were alkaline phosphatase-conjugated goat anti-mouse or anti-
rabbit IgG (Promega Corp., Madison).
2.3. Immunoﬂuorescence microscopy
The protocol of immunostaining was performed according to
the procedures described by Chen et al. (2008) [15].
2.4. Immunoprecipitation
The immunoprecipitation protocol was performed as described
by Chen et al. (2009) [16].
2.5. Western blotting
Gel electrophoresis and immunoblotting were performed as de-
scribed previously [17]. Densitometry was performed using Gel
Pro 3.1 (Media Cybernetics, Inc., Houston, Texas). The density of
theband in the control samplewasdeﬁnedas100%and thedensities
of theband in the test sample expressedas apercentageof this value.
2.6. Electroporation
HepG2 cells were detached from the dishes by mild digestion
with trypsin-EDTA and washed with RPMI 1640 medium contain-
ing 10% FBS and 1% penicillin/streptomycin (Gibco BRL, Grand Is-
land, NY). One hundred ll of NucleofectorTM V (Amaxa,
Germany) with 200 nM small interfering RNA (siRNA) was added
to 1  106 HepG2 cells and transferred into an Amaxa certiﬁed cuv-
ette. Electroporation was set at mode T-28 in the NucleofectorTM
apparatus. After electroporation, the cells were cultured in RPMI
medium for 48 h before processing for experiments. SiRNAs for
PKCd and PKCa (ON-TARGETplus SMART pool) were bought from
Dharmacon Corp. (Lafayette, CO). SiRNAs for c-Src (AAGUCAGACA-
CUGAGAGGC) and negative control containing a random sequence
were purchased from Applied Biosystems (Ambion, USA).
2.7. Intracellular calcium levels measured using Fluo-3/AM
HepG2 cells were washed once with normal Tyrode’s buffer
(NT) and loaded for 30 min at room temperature with 5 lM ﬂuo-
3/AM (Invitrogen). After loading with ﬂuo-3/AM, HepG2 cells were
trypsinized, washed with NT, and then incubated with NT with pH
7.4 or 6.6 for 30 min before measuring by ﬂow cytometry using
excitation at 488 nm.
2.8. Statistical analysis
All experiments were performed at least three times and the re-
sults expressed as the mean ± stander error of the mean. Statisticaldifferences between means were evaluated using the Kruskal–
Wallis test and corrected by Mann–Whitney test using SPSS soft-
ware. Differences were considered signiﬁcant if P < 0.05.
3. Results
3.1. PKCa and PKCd are activated by pH 6.6 treatment
Human hepatocellular carcinoma express predominantly ﬁve
isoforms (a, d, f, i and k), and PKCb, e, h and l are not detected
[18]. Analysis with ﬂow cytometry on Fluo-3/AM-incorporated
cells revealed that pH 6.6 treatment for 30 min increased intracel-
lular calcium concentration (Fig. 1A). Activation of PKCa and PKCd
were assessed using speciﬁc antibodies against phosphoserine
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Compared to the 0 min value, phosphorylation of PKCa was in-
creased after 30 min of pH 6.6 treatment (Fig. 1B), and phosphory-
lation of PKCd was increased at 60 min with a maximal intensity at
90 min (Fig. 1C).
3.2. PKCa and d mediate pH 6.6-induced dephosphorylation of p120-
ctn
HepG2 cells appear to express two isoforms of p120-ctn, the
120 and 100 kDa isoforms [19]. In cells incubated at pH 6.6 for
1 h, serine phosphorylation levels of the p120 and p100 isoforms
were decreased (Fig. 2A and B), while the total protein levels of
p120 and p100 isoforms were unchanged (Fig. 2C). Next, we exam-
ined the effect of the inhibitors of PKCa and d on pH 6.6-induced
p120-ctn dephosphorylation. Although Gö6976 is an inhibitor for
PKCa and PKCb, however, HepG2 cells mainly express a isoform,
but not PKCb. It is reasonable to consider that Gö6976 speciﬁcally
inhibits PKCa activity in human HepG2 cells. Rottlerin has been
used as a PKCd inhibitor [20,21]. Gö6976 and rottlerin were effec-Fig. 2. PKCa and PKCd activations reduced serine phosphorylation of p120-ctn. The
control groups were incubated in culture medium at pH 7.4 for 1 h, and the other
groups were incubated at pH 6.6 in the absence or presence of 1 lM Gö6976 or
5 lM rottlerin for 1 h. The cell lysates were precipitated with anti-phosphoserine
(A) or anti-p120-ctn antibodies (B), and the immunoprecipitates analyzed by
blotting for p120-ctn (A) or phosphoserine (B) and IgG-HC (heavy chain) or IgG-LC
(light chain). n = 4. ⁄P < 0.05, compared to the pH 7.4 control-group. #P < 0.05,
compared to pH 6.6-group. Furthermore, the cell homogenates were blotted for
p120-ctn and GAPDH under the aforementioned conditions (Fig. 2C).tive in preventing the pH 6.6-decreased serine dephosphorylation
of p120-ctn (Fig. 2A), demonstrating that PKCa and PKCdmediated
p120-ctn serine dephosphorylation under the condition of pH 6.6.
Next, we conﬁrmed the involvement of PKCa and PKCd in the
regulation of junctional p120-ctn distribution by inhibitor treat-
ment and siRNA approach. Fig. 3A shows that siPKCa and siPKCd
downregulated about 60% of PKCa and 50% of PKCd expressions
compared to the negative control siRNA group. Transfecting cells
with negative control siRNA and then culturing cells at pH 7.4
and at pH 6.6, p120-ctn staining showed the similar distribution
patterns as observed in cells at pH 7.4 (Fig. 3B-a) and pH 6.6
(Fig. 3B-b), respectively. The distribution of p120-ctn appeared lin-
ear and continuous staining in both siRNA PKCa (Fig. 3B-f) and siR-
NA PKCd groups (Fig. 3B-i) under pH 6.6. Treatment with Gö6976
or rottlerin alone at pH 7.4 did not change the normal distribution
of p120-ctn at AJ (Fig. 3B–d and g). Pharmacological inhibition of
PKCa (Fig. 3B-e) or PKCd (Fig. 3B–f) also prevented p120-ctn
detachment from cell junctions induced by pH 6.6. Further, PKCa
and PKCd siRNAs were effective in inhibiting the serine dephospho-
rylation of p120-ctn induced by acidic pHe (Fig. 3C).
3.3. Establishment of the c-Src kinase-PKCd cascade in HepG2 cells
Other investigators reported that c-Src acts as an upstream reg-
ulator of PKCd [22,23]. Inhibition of Src kinase activity by PP2
greatly prevented the pH 6.6-induced PKCd tyrosine phosphoryla-
tion (Fig. 4A). To ascertain whether c-Src was the upstream of
PKCd, we used siRNA of c-Src to knockdown c-Src levels and then
examined the expressions of phosphorylated PKCd. As expected,
siRNA of c-Src, which decreased 80% of the c-Src protein expres-
sions (Fig. 4B), prevented the tyrosine phosphorylation of PKCd in-
duced by pH 6.6 (Fig. 4C). These results support the presence of the
c-Src-PKCd signaling pathway in HepG2 cells. Fig. 5 is a schematic
representation of the acidic pHe-induced signaling pathways for
p120-ctn serine dephosphorylation.4. Discussion
Our previous studies have shown that culturing HepG2 cells at
pH 6.6 enhanced migratory potential with activation of c-Src and
Fyn, tyrosine phosphorylation of b-ctn and E-cadherin, and disas-
sembly of AJs [15,16]. This study further demonstrated that
p120-ctn was serine-dephosphorylated by PKCa/PKCd under pH
6.6 condition. This modiﬁcation on p120-ctn contributes to p120-
ctn detachment from the cell junction.
Serine/threonine phosphorylation of p120-ctn has been re-
ported to affect the integrity of AJs [12,24,25]. Xia et al. (2003) re-
ported that several residues (Ser122, Ser252, Ser268, Ser288,
Thr310, Ser312, Ser873, and Thr910) in p120ctn can be either
phosphorylated or dephosphorylated upon PKC activation [12].
PKC activation increases the permeability of MDCK cells, which is
accompanied by dephosphorylation of p100-/p120-ctn on serine
and threonine residues [11]. In contrast, platelet-derived growth
factor receptor activates PKCa and increases Ser879 phosphoryla-
tion of p120-ctn in A431 epidermal carcinoma and weakens AJ
[13]. Here, we found that PKCa activation led to the serine dephos-
phorylation of p120ctn and AJ disruption in HepG2 cells. The dis-
crepancy might be explained by that the different cell models
and stimuli were used in these studies. Serine/threonine protein
phosphatases might be involved in the dephosphorylation of
p120-ctn. Some protein phosphatases are under the control of SFKs
[26,27]. It is possible that an acidic pHe might activate protein
phosphatases directly or indirectly by SFK.
Several lines of evidence support the presence of cross-talk be-
tween SFKs and PKC. Activation of SFKs leads to the activation of
Fig. 3. Effect of inhibitors and siRNA knock-down of PKCa and PKCd expressions on pH 6.6-induced p120-ctn redistribution and phosphorylation. (A) Transfection efﬁciency.
The cells were transfected with siRNA-PKCa, siRNA-PKCd or siRNA-Neg for 48 h, then the cell homogenates were analyzed by blotting for PKCa, PKCd and b-actin (loading
control). n = 4. ⁄⁄P < 0.01, compared to the si-Neg-group. (B) Immunoﬂuorescence analysis. Immunostaining of p120-ctn was performed after transfection with siRNA-Neg (c),
siRNA-PKCa (f), siRNA-PKCd (i), then incubated for 5 h at pH 7.4 (a, d, g) or 6.6 (b, c, e, f, h, i). HepG2 cells were incubated at pH 7.4 plus 1 lM Gö6976 (d) or 5 lM rottlerin (g)
or at pH 6.6 for 5 h plus 1 lM Gö6976 (e) or 5 lM rottlerin (h), and then processed for p120-ctn staining. Bar = 20 lm. (C) pH 6.6 induces PKCa- and PKCd-dependent serine
dephosphorylation of p120-ctn. HepG2 cells were transfected with siRNA-Neg, siRNA-PKCa or siRNA-PKCd, and then cultured at pH 6.6 for 1 h. The cell lysates were
immunoprecipitated with anti-phosphoserine antibody and analyzed for p120-ctn or IgG-HC (loading control). n = 3. ⁄P < 0.05, compared to the pH 7.4 control-group.
#P < 0.05, compared to pH 6.6-group.
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family kinase members (c-Src, Fyn, Yes, and Lyn) [29]. In A431
cells, tyrosine phosphorylation of PKCd at Y311 prevented the
binding of PKCd to E-cadherin, and this tyrosine phosphorylation
of PKCd by epidermal growth factor was mediated by Src kinase[23]. This study provides evidence that PKCd is activated by c-Src
kinase in HepaG2 cells.
In conclusion, this study demonstrates that pH 6.6 treatment
activates PKCa by increasing intracellular calcium levels and acti-
vates PKCd via the c-Src kinase. Activation of both PKC isoforms de-
Fig. 4. Activation of c-Src-PKCd pathway by pH 6.6. (A) Effect of PP2 on PKCd
phosphorylation. The cells were cultured at pH 7.4, 6.6 or 6.6 plus 10 lM PP2 for 1 h
and then the cell homogenates were analyzed for phosphorylated Y311-PKCd.
GADPH is internal control. n = 4. ⁄P < 0.05, compared to the pH 7.4 group. #P < 0.05,
compared to the pH 6.6 group. (B) Down-regulation of siRNA for cSrc. The cells were
transfected with siRNA-cSrc or siRNA-Neg for 48 h, then the cell homogenates were
analyzed by blotting for cSrc and GAPDH. n = 4. ⁄⁄P < 0.01, compared to the siNeg-
group. (C) Effect of siRNA-cSrc on PKCd phosphorylation. The cells were transfected
with siRNA-c-Src or siRNA-Neg, then incubated at pH 6.6 for 1 h. The cell lysates
were analyzed for phosphorylated Tyr311-PKCd and GADPH. n = 5. ⁄P < 0.05,
compared to the si-Neg-pH 7.4-group. #P < 0.05, compared to the si-Neg-pH 6.6-
group.
Fig. 5. Signaling pathways of an acidic extracellular pH on p120-ctn
phosphorylation.
Y. Chen et al. / FEBS Letters 585 (2011) 705–710 709creased serine phosphorylation of p120-ctn, and caused AJ
disassembly.
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